{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:53:39Z","timestamp":1778900019488,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1016\/j.metabol.2003.06.003","type":"journal-article","created":{"date-parts":[[2003,12,2]],"date-time":"2003-12-02T08:23:42Z","timestamp":1070353422000},"page":"1638-1642","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis"],"prefix":"10.1016","volume":"52","author":[{"given":"D","family":"Maggs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Strobel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Kolterman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Weyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2003.06.003_BIB1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2003.06.003_BIB2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood glucose control on metformin with complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2003.06.003_BIB3","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"Overview of 6 years\u2019 therapy of type II diabetes","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2003.06.003_BIB4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulphonylureas, metformin, or insulin in patients with type 2 diabetes mellitus (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2003.06.003_BIB5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00024677-200302010-00004","article-title":"Weight effect of current and experimental drugs for diabetes mellitus","volume":"2","author":"Purnell","year":"2003","journal-title":"Treat Endocrinol"},{"key":"10.1016\/j.metabol.2003.06.003_BIB6","series-title":"Difficult Diabetes","first-page":"94","article-title":"Should obese type 2 diabetic patients be treated with insulin","author":"Riddle","year":"2001"},{"key":"10.1016\/j.metabol.2003.06.003_BIB7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2337\/diacare.16.1.21","article-title":"Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial","volume":"16","author":"Henry","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.06.003_BIB8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"131","author":"DeFronzo","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2003.06.003_BIB9","first-page":"3","article-title":"Post-prandial hyperglycaemia\u2014the necessity for better control","volume":"112","author":"Del Prato","year":"2000","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/j.metabol.2003.06.003_BIB10","first-page":"S27","article-title":"Postprandial hyperglycaemic state","volume":"40","author":"Lebovitz","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2003.06.003_BIB11","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/0895-4356(94)90105-8","article-title":"Is race related to glycemic control? An assessment of glycosylated hemoglobin in two South Carolina communities","volume":"47","author":"Eberhardt","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.metabol.2003.06.003_BIB12","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.2337\/diacare.17.10.1148","article-title":"Glycemic control in a sample of black and white clinic patients with NIDDM","volume":"17","author":"Weatherspoon","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.06.003_BIB13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/diacare.20.6.971","article-title":"Comparison of laboratory test frequency and test results between African-Americans and Caucasians with diabetes","volume":"20","author":"Wisdom","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.06.003_BIB14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2337\/diacare.22.3.403","article-title":"Racial and ethnic differences in glycemic control of adults with type 2 diabetes","volume":"22","author":"Harris","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.06.003_BIB15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.21.4.510","article-title":"Ethnic differences in the glycemic response to exogenous insulin treatment in the Veterans Affairs Cooperative Study in type 2 diabetes mellitus (VA CSDM)","volume":"21","author":"Agrawal","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.06.003_BIB16","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2174\/1381612013397357","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus","volume":"7","author":"Weyer","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.metabol.2003.06.003_BIB17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/15209150260007390","article-title":"Unresolved challenges with insulin therapy in type 1 and type 2 diabetes","volume":"4","author":"Edelman","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.metabol.2003.06.003_BIB18","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/diaclin.20.3.137","article-title":"Amylin replacement with pramlintide in type 1 and type 2 diabetes","volume":"20","author":"Buse","year":"2002","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.metabol.2003.06.003_BIB19","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0140-6736(92)90785-2","article-title":"Amylin concentrations and glucose control","volume":"339","author":"Koda","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2003.06.003_BIB20","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/(SICI)1096-9136(199707)14:7<547::AID-DIA390>3.0.CO;2-U","article-title":"Pramlintide","volume":"14","author":"Thompson","year":"1997","journal-title":"Diabet Med"},{"issue":"suppl 2","key":"10.1016\/j.metabol.2003.06.003_BIB21","first-page":"A264","article-title":"Mealtime amylin replacement with pramlintide markedly improves postprandial glucose excursions when added to insulin lispro in patients with type 2 diabetes","volume":"45","author":"Maggs","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2003.06.003_BIB22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2002-34790","article-title":"The human amylin analog, pramlintide, reduces postprandial hyperglucagonemia in patients with type 2 diabetes mellitus","volume":"9","author":"Fineman","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.metabol.2003.06.003_BIB23","doi-asserted-by":"crossref","first-page":"A624","DOI":"10.1016\/S0016-5085(00)84636-3","article-title":"Vagal inhibition in the retardation of gastric emptying of solids by the amylin analog, pramlintide, in diabetes mellitus","volume":"118","author":"Lee","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2003.06.003_BIB24","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diacare.26.3.784","article-title":"Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes mellitus","volume":"26","author":"Hollander","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2003.06.003_BIB25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/15209150252924094","article-title":"Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated patients with type 2 diabetes","volume":"4","author":"Ratner","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.metabol.2003.06.003_BIB26","series-title":"Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation","year":"2000"},{"key":"10.1016\/j.metabol.2003.06.003_BIB27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/014572179301900411","article-title":"Non-insulin-dependent diabetes and obesity in the black and Hispanic population","volume":"19","author":"Raymond","year":"1993","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.metabol.2003.06.003_BIB28","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF02064382","article-title":"Gastric emptying in Mexican Americans compared to non-Hispanic whites","volume":"40","author":"Schwartz","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.metabol.2003.06.003_BIB29","first-page":"A302","article-title":"Comparison of central and peripheral administration of amylin on reduction of food intake in rats","volume":"40","author":"Bhavsar","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2003.06.003_BIB30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/endo.141.2.7378","article-title":"Amylin","volume":"141","author":"Rushing","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.metabol.2003.06.003_BIB31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/sj.ijo.0801664","article-title":"The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema\/nucleus of the solitary tract (AP\/NTS) lesioned rats","volume":"25","author":"Lutz","year":"2001","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049503003664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049503003664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:59:55Z","timestamp":1758419995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049503003664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["S0026049503003664"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2003.06.003","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2003,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of pramlintide on A1C and body weight in insulin-treated African Americans and Hispanics with type 2 diabetes: a pooled post hoc analysis","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2003.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}